Search Results - Dirk Garmann
- Showing 1 - 5 results of 5
-
1
-
2
-
3
Item response theory analysis of daytime sleepiness as a symptom of obstructive sleep apnea by Gustaf J. Wellhagen, Mats O. Karlsson, Maria C. Kjellsson, Dirk Garmann, Astrid Bröker, Yang Zhang, Mika Nokela, Gerrit Weimann, Ashraf Yassen
Published in CPT: Pharmacometrics & Systems Pharmacology (2024-05-01)Get full text
Article -
4
Copanlisib population pharmacokinetics from phase I–III studies and exposure–response relationships in combination with rituximab by Peter N. Morcos, Jonathan Moss, Rupert Austin, Florian Hiemeyer, Pier Luigi Zinzani, Vita Beckert, Lidia Mongay Soler, Barrett H. Childs, Dirk Garmann
Published in CPT: Pharmacometrics & Systems Pharmacology (2023-11-01)Get full text
Article -
5
Model‐informed approach to support pediatric dosing for the pan‐PI3K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors by Peter N. Morcos, Jan Schlender, Rolf Burghaus, Jonathan Moss, Adam Lloyd, Barrett H. Childs, Margaret E. Macy, Joel M. Reid, John Chung, Dirk Garmann
Published in Clinical and Translational Science (2023-07-01)Get full text
Article
